e18106Background: Management of advanced differentiated thyroid cancer refractory to radio-iodine (RAI) has taken a new turn with the results of SELECT trial. Physicians are learning to use lenvati... Click to show full abstract
e18106Background: Management of advanced differentiated thyroid cancer refractory to radio-iodine (RAI) has taken a new turn with the results of SELECT trial. Physicians are learning to use lenvati...
               
Click one of the above tabs to view related content.